CYTOVALE
Dead / Abandoned — Abandoned — no statement of use filed (as of 11 Dec 2023)
What this means for you
This application is over — abandoned 11 Dec 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88950318
- Mark type
- Stylized text
- Filed
- 05 Jun 2020
- Published for opposition
- 14 Sept 2021
- Abandoned
- 11 Dec 2023
- Attorney of record
- Holly Pranger
Goods and services
- Class 010 — Medical apparatus: medical diagnostic apparatus for analysis of biomarker levels and/or relative expression of host response genes, medical diagnostic apparatus for analyzing gene expression tests using bioinformatics and machine learning algorithms, medical diagnostic apparatus for analyzing gene expression tests, gene expression profiling assays, genetic information, protein biomarkers, clinical data and/or demographic information to aid treatment decisions; sample preparation devices in the nature of lyse wash assistant being automated sample preparation instruments capable of lysing, washing, mixing, and fixing samples that are then ready for analysis on a flow cytometer TQ-prep workstations for standardizing whole blood lysis for flow cytometric analysis and related recorded data management software sold as a unit; diagnostic test apparatus for medical use for analysis of gene expression, protein expression, metabolite expression, inflammation, immune- suppression, immune disorders; medical and diagnostic apparatus for medical use in analysis of gene expression tests, analysis of gene expression profiling assays, analyzing genetic information, analyzing and detecting protein biomarkers, analyzing clinical data, and/or analyzing demographic information; point of care medical devices, namely, polymerase chain reaction (pcr) testing equipment for analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders; medical testing kits for cancer and other immune-mediated conditions; apparatus for diagnostic purposes, namely, medical diagnostic apparatus for testing for cancer and other immune-mediated conditions in the fields of oncology and hematology; ultraviolet visible and near infrared fluorescence analyzers for medical use and components therefor; imaging platforms, namely, medical imaging apparatus for imaging and analysis of cells and cell organelles, molecular diagnostics and imaging cytometry for medical use; medical apparatuses for the examination and analysis of proteins, peptides, antibodies and molecules for medical diagnostic use and components therefor; diagnostic apparatus for medical use, namely, computed tomography scanners, fluorescent microscope systems comprised of optical detection modalities, magnification objective for use in performing fluorescent antibody technique analysis and fluorescent protein technique analysis, automatic cell sorting systems comprised of single-cell analysis, optical detection modalities, electrical detection modalities, mechanical detection modalities for use in flow cytometry analysis and in fluorescence activated cell sorting; flow cytometers
- Class 044 — Medical, beauty and agricultural services: medical services; medical treatment of sepsis, cancer and immune-mediated diseases; medical analysis services in the fields of cytometry, oncology, and hematology
Owner
- Cytovale Inc., San Francisco, CA, US
- Cytovale Inc., San Francisco, CA, US
Prosecution history
- 11 Dec 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 11 Dec 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 10 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 May 2023 — SOU EXTENSION 3 GRANTED
- 08 May 2023 — SOU EXTENSION 3 FILED
- 08 May 2023 — SOU TEAS EXTENSION RECEIVED
- 17 Jan 2023 — ASSIGNED TO EXAMINER
- 05 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Nov 2022 — SOU EXTENSION 2 GRANTED
- 02 Nov 2022 — SOU EXTENSION 2 FILED
- 02 Nov 2022 — SOU TEAS EXTENSION RECEIVED
- 20 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 May 2022 — CORRECTED NOA E-MAILED
- 19 May 2022 — SOU EXTENSION 1 GRANTED
- 09 May 2022 — SOU EXTENSION 1 FILED